Sean Senn - Net Worth and Insider Trading

Sean Senn Net Worth

The estimated net worth of Sean Senn is at least $2 Million dollars as of 2024-12-13. Sean Senn is the 10% Owner of Immix Biopharma Inc and owns about 899,800 shares of Immix Biopharma Inc (IMMX) stock worth over $2 Million. Details can be seen in Sean Senn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean Senn has not made any transactions after 2022-07-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Sean Senn

To

Sean Senn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sean Senn owns 1 companies in total, including Immix Biopharma Inc (IMMX) .

Click here to see the complete history of Sean Senn’s form 4 insider trades.

Insider Ownership Summary of Sean Senn

Ticker Comapny Transaction Date Type of Owner
IMMX Immix Biopharma Inc 2022-07-14 10 percent owner

Sean Senn Latest Holdings Summary

Sean Senn currently owns a total of 1 stock. Sean Senn owns 899,800 shares of Immix Biopharma Inc (IMMX) as of July 14, 2022, with a value of $2 Million.

Latest Holdings of Sean Senn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMMX Immix Biopharma Inc 2022-07-14 899,800 2.13 1,916,574

Holding Weightings of Sean Senn


Sean Senn Form 4 Trading Tracker

According to the SEC Form 4 filings, Sean Senn has made a total of 2 transactions in Immix Biopharma Inc (IMMX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Immix Biopharma Inc is the sale of 200 shares on July 14, 2022, which brought Sean Senn around $550.

Insider Trading History of Sean Senn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sean Senn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sean Senn Ownership Network

Ownership Network List of Sean Senn

No Data

Ownership Network Relation of Sean Senn

Insider Network Chart

Sean Senn Owned Company Details

What does Immix Biopharma Inc do?

Who are the key executives at Immix Biopharma Inc?

Sean Senn is the 10 percent owner of Immix Biopharma Inc. Other key executives at Immix Biopharma Inc include director & CEO and Chairman Ilya M Rachman , director & Chief Financial Officer Gabriel S Morris , and director & 10 percent owner Yekaterina Chudnovsky .

Immix Biopharma Inc (IMMX) Insider Trades Summary

Over the past 18 months, Sean Senn made no insider transaction in Immix Biopharma Inc (IMMX). Other recent insider transactions involving Immix Biopharma Inc (IMMX) include a net purchase of 170,300 shares made by Jason Hsu , a net purchase of 20,000 shares made by Magda Marquet , and a net purchase of 10,300 shares made by Gabriel S Morris .

In summary, during the past 3 months, insiders sold 0 shares of Immix Biopharma Inc (IMMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immix Biopharma Inc (IMMX) were sold and 263,800 shares were bought by its insiders, resulting in a net purchase of 263,800 shares.

Immix Biopharma Inc (IMMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immix Biopharma Inc Insider Transactions

No Available Data

Sean Senn Mailing Address

Above is the net worth, insider trading, and ownership report for Sean Senn. You might contact Sean Senn via mailing address: 11400 West Olympic Blvd., Suite 200, Los Angeles Ca 90064.